Ibogaine and Prednisone

Moderate caution. Systemic corticosteroids drive renal potassium excretion through mineralocorticoid receptor activity, and can lower magnesium secondarily. The effect is dose-dependent and becomes clinically relevant around 10 mg prednisone-equivalent daily or above; short low-dose or purely topical/inhaled use is a much smaller concern. Steroids also raise blood glucose, which matters during a fasting protocol. Record the DOSE, not just the drug — a 5 mg maintenance dose and a 60 mg burst are different exposures. At 10 mg prednisone-equivalent or more, measure K+ and Mg2+ before dosing. Never stop a chronic steroid abruptly: adrenal suppression is the larger danger and any change belongs to the prescribing physician.

Continue as prescribed — cleared by a measured lab value, not a waiting period. This medication is not stopped for treatment, and should not be stopped on our initiative — the condition it treats usually outranks the interaction. What it changes is monitoring: serum potassium and magnesium are measured before the flood dose and corrected to target, and the dose is deferred until those numbers are right rather than until a number of days have passed. Any change to the prescription belongs to the prescribing physician.

Electrolyte disturbance. QTc is exquisitely sensitive to potassium and magnesium. Diuretics, laxatives, and conditions that lower these electrolytes lengthen QT and add to ibogaine's hERG effect. Pre-treatment electrolyte panels and IV repletion are routine.

In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Prednisone — contact us for an individual review.